Could donating blood help control diabetes and fatty liver?

NCT ID NCT00230087

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study investigates whether reducing iron levels in the body through blood donation can improve insulin sensitivity and liver function in people with type 2 diabetes and non-alcoholic fatty liver disease. Participants will undergo phlebotomy until their iron stores are depleted. The goal is to see if this leads to better diabetes control and less fat in the liver.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
blood donation (phlebotomy) to reduce iron levels
What this could lead to
If it works, this could point toward a simple, low-cost way to improve diabetes control and reduce liver fat in people with type 2 diabetes and fatty liver disease.
What could go wrong
This is a very small early study with only 15 participants, so results may not apply to everyone. Lowering iron may not improve insulin sensitivity or liver health as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Washington Medical Center

    Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.